Riggs Asset Managment Co. Inc. - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 342 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.

Quarter-by-quarter ownership
Riggs Asset Managment Co. Inc. ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$3,0000.0%350.0%0.00%0.0%
Q2 2021$3,0000.0%350.0%0.00%0.0%
Q1 2021$3,000
-50.0%
350.0%0.00%
-50.0%
Q4 2020$6,000
-93.8%
35
-88.9%
0.00%
-95.1%
Q3 2020$97,000
+1840.0%
314
+797.1%
0.04%
+1950.0%
Q2 2020$5,000
+66.7%
350.0%0.00%0.0%
Q1 2020$3,000
-40.0%
350.0%0.00%0.0%
Q4 2019$5,000
+150.0%
350.0%0.00%
+100.0%
Q3 2019$2,000
-60.0%
350.0%0.00%
-66.7%
Q2 2019$5,000
+25.0%
350.0%0.00%0.0%
Q1 2019$4,0000.0%350.0%0.00%0.0%
Q4 2018$4,000
-20.0%
350.0%0.00%
+50.0%
Q3 2018$5,0000.0%350.0%0.00%0.0%
Q2 2018$5,000
+66.7%
350.0%0.00%
+100.0%
Q1 2018$3,000
+50.0%
350.0%0.00%0.0%
Q4 2017$2,0000.0%350.0%0.00%0.0%
Q3 2017$2,000
+100.0%
350.0%0.00%
Q2 2017$1,0000.0%350.0%0.00%
-100.0%
Q1 2017$1,0000.0%350.0%0.00%
Q4 2016$1,000
-50.0%
350.0%0.00%
-100.0%
Q3 2016$2,000
+100.0%
35
-53.3%
0.00%0.0%
Q2 2016$1,0000.0%750.0%0.00%0.0%
Q1 2016$1,000
-66.7%
750.0%0.00%0.0%
Q4 2015$3,000
+50.0%
750.0%0.00%0.0%
Q3 2015$2,0000.0%750.0%0.00%0.0%
Q2 2015$2,000
+100.0%
750.0%0.00%
Q1 2015$1,0000.0%750.0%0.00%
Q4 2014$1,000
-50.0%
750.0%0.00%
-100.0%
Q3 2014$2,000750.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Evolutionary Tree Capital Management, LLC 68,937$5,138,0003.04%
Avoro Capital Advisors LLC 2,150,000$160,240,0002.77%
Casdin Capital, LLC 550,000$40,992,0001.22%
TOBAM 371,107$27,659,0001.18%
Ikarian Capital, LLC 455,900$33,978,0001.14%
Eventide Asset Management 697,156$51,959,0000.77%
FOX RUN MANAGEMENT, L.L.C. 4,902$365,0000.66%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 31,500$2,348,0000.62%
Sivik Global Healthcare LLC 20,000$1,491,0000.54%
Rock Springs Capital Management LP 328,750$24,502,0000.54%
View complete list of SAREPTA THERAPEUTICS INC shareholders